Pioneer work on cellular response to DNA Damage wins GlaxoSmithKline award
Steve Jackson has emerged as one of the international leaders in the field of recombinational repair, structure of damaged chromatin and cellular DNA damage. The medical relevance of this work is that defects in these processes are the cause of many diseases, most notably cancer.
Steve’s work is leading to clinical trials of drugs being developed that may be effective at killing cells mutant for breast cancer susceptibility genes BRAC1 and BRAC2.
The Biochemical Society’s GlaxoSmithKline award winner receives a beautiful glass sculpture designed by the Katharine Dowson.
Stephen Jackson is the Frederick James Quick Professor of Biology and the Head of Cancer Research UK Laboratories, The Wellcome Trust and cancer Research UK Gurdon Institute, University of Cambridge. Stephen’s PhD was at University of Edinburgh with Professor Jean Beggs. After a spell at University of California with Professor Roger Tjian he returned to the UK to work at the Wellcome Trust and Cancer Research Campaign Institute.
Media Contact
More Information:
http://www.biochemistry.orgAll latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…
